Amorphical brings Scientific Breakthrough - Treating and Curing Chronic Inflammatory and Oncological Diseases

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Amorphical

More Like This

The structural model of amorphous carbon (left), estimated by TXS-RMC using SmartLab (right) (Graphic: Business Wire)

Rigaku Develops Technology for 3D Visualization of the Atomic-scale Structure of Amorphous Carbon

Arctic Therapeutics research suggests preventative strategy against HCCAA

Inside information made public: Nanoform Announces Important Milestone with Promising Clinical Results for Patient-Centric Nanotechnology-Enhanced Enzalutamide

Nanoform Commenced Relative Bioavailability Study of Nanotechnology-Enhanced Enzalutamide

Dr. Aron Blaesi, inventor of expandable, gastroretentive fibrous dosage forms presenting dosage forms before and after expansion due to water absorption. (Photo: Business Wire)

Enzian Pharmaceutics Develops a Novel Dosage Form for Enhanced Efficacy and Reduced Side Effects of Cancer Therapies

Nanoform's biologics technology showcased by large pharma at drug delivery conference; Nanoenzalutamide and nanoapalutamide partnering discussions progress as planned

GlobeNewswire associated0

Journal of Clinical Nuclear Medicine Publishes Results of Tiziana’s Nasal Foralumab in Study Treating Moderate Alzheimer's Disease

PR Newswire associated0

Agepha Pharma and Caristo Diagnostics Team Up to Fight Coronary Inflammation